GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $339,000 | -9.6% | 1,563 | -51.9% | 0.00% | -25.0% |
| Q4 2020 | $375,000 | -8.8% | 3,251 | -23.0% | 0.00% | -20.0% |
| Q3 2020 | $411,000 | -10.7% | 4,220 | +12.6% | 0.01% | -16.7% |
| Q2 2020 | $460,000 | +56.5% | 3,749 | +11.8% | 0.01% | +20.0% |
| Q1 2020 | $294,000 | -27.4% | 3,354 | -13.4% | 0.01% | -16.7% |
| Q4 2019 | $405,000 | +19.1% | 3,872 | +31.2% | 0.01% | +20.0% |
| Q3 2019 | $340,000 | -69.5% | 2,952 | -54.3% | 0.01% | -68.8% |
| Q2 2019 | $1,113,000 | +5.4% | 6,459 | +3.1% | 0.02% | 0.0% |
| Q1 2019 | $1,056,000 | +97.4% | 6,262 | +14.0% | 0.02% | +60.0% |
| Q4 2018 | $535,000 | -37.3% | 5,491 | +11.2% | 0.01% | -28.6% |
| Q3 2018 | $853,000 | +171.7% | 4,939 | +119.4% | 0.01% | +100.0% |
| Q2 2018 | $314,000 | – | 2,251 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |